Biotest AG (Biotest AG) Long-Term Debt : $0.0 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Biotest AG Long-Term Debt?

Biotest AG's Long-Term Debt for the quarter that ended in Mar. 2024 was $0.0 Mil.

Biotest AG's quarterly Long-Term Debt increased from Sep. 2023 ($0.0 Mil) to Dec. 2023 ($359.3 Mil) but then declined from Dec. 2023 ($359.3 Mil) to Mar. 2024 ($0.0 Mil).

Biotest AG's annual Long-Term Debt increased from Dec. 2021 ($528.7 Mil) to Dec. 2022 ($572.6 Mil) but then declined from Dec. 2022 ($572.6 Mil) to Dec. 2023 ($359.3 Mil).

Biotest AG Long-Term Debt Historical Data

The historical data trend for Biotest AG's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Long-Term Debt Chart

Biotest AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

421.78

533.09

528.70

572.56

359.32

Biotest AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															-	-	-	359.32	-

Biotest AG (OTCPK:BIESF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Biotest AG Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Biotest AG's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotest AG (Biotest AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (OTCPK:BIESF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

BIO3:Germany BIO3:Austria

Address

Landsteinerstrasse 5, Dreieich, DEU, 63303

Website

https://www.biotest.com

Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.